Winship Virtual 5K: Meet the Rosses

The virtual Winship Win the Fight 5K is just weeks away. Winship cancer survivors Bari and Charlie Ross explain their deep commitment to Winship and why they’re in this year’s virtual Winship 5K. Visit the website to register, see more inspiring videos, and learn about participating virtually.

Watch Video

Clinical trial leads to FDA approval of thyroid cancer treatment

An international Phase I-II clinical trial evaluated at Winship has led to FDA approval of selpercatinib to treat RET-altered thyroid cancers. The results of the study, co-authored by Taofeek Owonikoko, MD, PhD, were published on Aug. 27 in the New England Journal of Medicine.

Bradley celebrated as Keller distinguished professor

Jeffrey Bradley, MD was celebrated as the James W. Keller Distinguished Professor in Radiation Oncology on Aug. 31. The virtual ceremony included remarks from Bradley as well as Drs. Jan Love, Deborah Watkins Bruner, Walter J. Curran, Jr., and James W. Keller.

Cooper to present Morgan Distinguished Faculty Lecture

Max Cooper, PhD will deliver the 2020 John F. Morgan, Sr. Distinguished Faculty Lecture virtually at 6pm on Sept. 8, titled “How Did Our Immune System Evolve?”

Learn More

Ahmed to present at Cancer Immunology meeting

Rafi Ahmed, PhD will present "T Cell Lifestyle in Cancer: Implications for Immunotherapy" at Winship's Cancer Immunology Research Program meeting at noon on Sept. 10.

Learn More

Video: communities of color urged to get screened for colon cancer

Jennifer Christie, MD discussed colorectal cancer in a segment that aired on FOX 5 Atlanta on Sept. 1, days after actor Chadwick Boseman died of the disease.

Watch Video

Georgia Blood Cancer Conference to feature Winship specialists

Drs. Martha Arellano, William Blum, and Wendy Baer will discuss research, treatment, and survivorship at The Leukemia & Lymphoma Society Virtual Georgia Blood Cancer Conference, a free community event on Sept. 26.

Shared Resource spotlight: Imaging

Winship's 11 shared resources offer advanced technologies and services to support cancer researchers. The Integrated Cellular Imaging Shared Resource provides cutting-edge fluorescence microscopy imaging including confocal, spinning-disk, multi-photon, widefield, super-resolution, and light sheet, with live cell available on all types. Assistance and training is offered at all stages, from bench to publication, including a wide variety of quantitative data analyses and visualizations. Contact the core for a free consultation or a tailored presentation for your group or department.

Learn More

Report highlights faculty advancement, leadership and inclusion

Emory University School of Medicine's Office of Faculty Academic Advancement, Leadership and Inclusion has issued an annual report, which highlights faculty advancement, diversity, equity & inclusion, and wellness programs from its first year of operation.

Read the Report

Davis to deliver virtual Elkin lecture

Winship virtual Elkin lectures continue via Zoom webinar on Sept. 11 with Anthony Davis, PhD of UT Southwestern Medical Center. Davis will present, "The DNA-PK Complex Dictates the Immediate Response to DNA Double Strand Breaks." Winship's Elkin Lecture Series is held on Fridays at 12:15pm.

Add to Calendar

EIGC to host seminar on Tapestri Platform

Join the Emory Integrated Genomics Core (EIGC) and Mission Bio on Sept.18 at 10am to learn about different applications of the Tapestri Platform. This technology enables co-detection of SNVs, CNVs, and proteins from the same cell using a single workflow, allowing for deeper insight into systems biology and patterns of tumor/clonal evolution, therapy response, and resistance.

Learn More

Call for proposals: Emory Accelerator Grants

The Biological Discoveries Through Chemical Innovations (BDCI) program aims to promote basic research across Emory by supporting the translation of biological insights to chemical tools and the utilization of those tools to accelerate understanding of disease mechanisms. Up to five Accelerator pilot grants will be funded at $40,000 each. Applications are due Oct. 30.

Learn More